Pages that link to "Item:Q5001268"
From MaRDI portal
The following pages link to Discrete and continuum phenotype-structured models for the evolution of cancer cell populations under chemotherapy (Q5001268):
Displaying 18 items.
- Designing proliferating cell population models with functional targets for control by anti-cancer drugs (Q378938) (← links)
- Origins and evolution of cell phenotypes in breast tumors (Q781181) (← links)
- Evolution of a mathematical model of an aggressive-invasive cancer under chemotherapy (Q2006038) (← links)
- Evolutionary dynamics in vascularised tumours under chemotherapy: mathematical modelling, asymptotic analysis and numerical simulations (Q2022476) (← links)
- Phenotypic variation modulates the growth dynamics and response to radiotherapy of solid tumours under normoxia and hypoxia (Q2049113) (← links)
- Evolutionary dynamics in an SI epidemic model with phenotype-structured susceptible compartment (Q2059540) (← links)
- Evolution of a structured cell population endowed with plasticity of traits under constraints on and between the traits (Q2093250) (← links)
- Spatio-temporal modelling of phenotypic heterogeneity in tumour tissues and its impact on radiotherapy treatment (Q2109231) (← links)
- Mathematical model for the estrogen paradox in breast cancer treatment (Q2113532) (← links)
- A mathematical dissection of the adaptation of cell populations to fluctuating oxygen levels (Q2209433) (← links)
- Modeling continuous levels of resistance to multidrug therapy in cancer (Q2307049) (← links)
- Modeling the Emergence of Phenotypic Heterogeneity in Vascularized Tumors (Q4986537) (← links)
- Discrete and Continuum Models for the Evolutionary and Spatial Dynamics of Cancer: A Very Short Introduction Through Two Case Studies (Q5016714) (← links)
- A survey of adaptive cell population dynamics models of emergence of drug resistance in cancer, and open questions about evolution and cancer (Q5197818) (← links)
- Evolution of cancer cell populations under cytotoxic therapy and treatment optimisation: insight from a phenotype-structured model (Q5242218) (← links)
- Phenotype-structured model of intra-clonal heterogeneity and drug resistance in multiple myeloma (Q6192824) (← links)
- Optimal control in reducing side effects during and after chemotherapy of solid tumors (Q6562637) (← links)
- Mathematical modeling of combined therapies for treating tumor drug resistance (Q6566648) (← links)